The loss of ATRX increases susceptibility to pancreatic injury and oncogenic KRAS in female but not male mice
<strong>Background</strong> Pancreatic ductal adenocarcinoma (PDAC) is the third leading cause of cancer death in North America, accounting for >30,000 deaths annually. Although somatic activating mutations in KRAS appear in 97% of PDAC patients, additional factors are required to...
Main Authors: | Young, C, Baker, R, Howlett, C, Hryciw, T, Herman, J, Higgs, D, Gibbons, R, Crawford, H, Brown, A, Pin, C |
---|---|
Format: | Journal article |
Published: |
Elsevier
2018
|
Similar Items
-
The Loss of ATRX Increases Susceptibility to Pancreatic Injury and Oncogenic KRAS in Female But Not Male MiceSummary
by: Claire C. Young, et al.
Published: (2019-01-01) -
ATRX: taming tandem repeats.
by: Gibbons, R, et al.
Published: (2010) -
Acquired somatic ATRX mutations in myelodysplastic syndrome associated with alpha thalassemia (ATMDS) convey a more severe hematologic phenotype than germline ATRX mutations.
by: Steensma, D, et al.
Published: (2004) -
Identification of mutations in ATRX by RNase mismatch cleavage.
by: Gibbons, R, et al.
Published: (1997) -
XNP/ATRX at sites of nucleosome replacement.
by: Garrick, D, et al.
Published: (2009)